Renal Outcomes in Patients with Systolic Heart Failure Treated With Sacubitril-Valsartan or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker

OBJECTIVE: To assess 4 adverse renal outcomes in a heterogeneous cohort of patients with systolic heart failure (HF) who were prescribed sacubitril-valsartan vs angiotensin-converting enzyme inhibitor/angiotensin receptor blocker (ACEi/ARB). PATIENTS AND METHODS: The OptumLabs Database Warehouse, wh...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mayo Clin Proc Innov Qual Outcomes
Autori principali: Tan, Nicholas Y., Deng, Yihong, Yao, Xiaoxi, Sangaralingham, Lindsey R., Shah, Nilay D., Rule, Andrew D., Burnett, John C., Dunlay, Shannon M., Sangaralingham, S. Jeson
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2021
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8105557/
https://ncbi.nlm.nih.gov/pubmed/33997628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mayocpiqo.2020.10.008
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi